Product Information

COSENTYX SENSOREADY 150 MG/ML PEN is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $7869.8320 per ML under NDC 00078063968. Its NADAC has been published 110 times since May 22, 2024.

COSENTYX SENSOREADY 150 MG/ML PEN

secukinumab
$7869.8320per ML

Strength

150 mg/mL

NDC

00078063968

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price Statistics

The NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has been published 110 times since May 22, 2024, and over the history we have for it it has risen 9.2%. The table below summarizes its recorded NADAC range and movement.

Current price$7869.8320 per ML
All-time high$7874.0281 (May 13, 2026)
All-time low$7198.5482 (Aug 21, 2024)
52-week high$7874.0281
52-week low$7356.9640
Median price$7366.1092
Average price$7434.7703
Largest weekly change+7.0% (Jan 14, 2026)
Weeks tracked110
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

0.0%

3M

-0.1%

6M

+6.9%

1Y

+7.0%

3Y

N/A

5Y

N/A

All

+9.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of COSENTYX SENSOREADY 150 MG/ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for COSENTYX SENSOREADY 150 MG/ML PEN, manufactured by Novartis Pharmaceuticals Corporation, is $7869.8320 per ML (NDC 00078063968), effective Jun 24, 2026.

How has the price of COSENTYX SENSOREADY 150 MG/ML PEN changed over time?

Over the history we have for it, the NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has risen 9.2%. It has been tracked across 110 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for COSENTYX SENSOREADY 150 MG/ML PEN?

Since May 22, 2024, the NADAC for COSENTYX SENSOREADY 150 MG/ML PEN has ranged from a low of $7198.5482 (Aug 21, 2024) to a high of $7874.0281 (May 13, 2026), with a median of $7366.1092 per ML.

Are there cheaper alternatives to COSENTYX SENSOREADY 150 MG/ML PEN?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), is $3961.2495 per ML — about 50% below COSENTYX SENSOREADY 150 MG/ML PEN.

Who manufactures COSENTYX SENSOREADY 150 MG/ML PEN?

COSENTYX SENSOREADY 150 MG/ML PEN (NDC 00078063968) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.